Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Javed Butler, Sanjiv Jayendra Shah, Mark Colquhoun Petrie, Barry A. Borlaug, Steen Zabell Abildstrom, Melanie Jane Davies, G. Kees Hovingh, Dalane W. Kitzman, Daniél V. Møller, Subodh Verma, Mette Nygaard Einfeldt, Marie L.S. Lindegaard, Søren Rasmussen, Walter P. Abhayaratna, Fozia Zahir Ahmed, Tuvia Ben Gal, Vijay Chopra, Justin Adrian Ezekowitz, Michael L.X. Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Péter Merkely, Julio E. Núñez, Eduardo Roque Perna, and 7 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(24)00469-0
- Published
- Apr 1, 2024
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(24)00469-0
- PubMed
- 38599221
- Categories
- Heart Failure Treatment and Management
- License
- cc-by-nc-nd
- Provenance
- openalex